Product Images Levetiracetam
View Photos of Packaging, Labels & Appearance
Product Label Images
The following 8 images provide visual information about the product associated with Levetiracetam NDC 43063-499 by Pd-rx Pharmaceuticals, Inc., such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.
This is a description of a medication containing LevETIRAcetam USP 500mg in tablet form. There are three bottles with 60 tablets each, and they have the same ReOrder and LOT numbers. The expiration date is 09/2021. The tablets are yellow, oval/brelined, with the marking 1015 500mg. The package insert provides only Dosage and Storage information, and there is a warning to keep away from children. The instructions indicate to take the tablet(s) 'times a day'. The text includes a phone number to call the doctor for medical advice about side effects, and to report side effects to the FDA. The last line is not readable.*
This is a chart depicting the percentage of patients in a study who were given a placebo or varying doses of levetiracetam, a medication commonly used to treat epilepsy. The percentages represent the proportion of patients in each group, with 35.2% receiving a placebo, 20.8% receiving 1000mg/day of levetiracetam, and 6.3% receiving 2000mg/day of levetiracetam. The study included 111 patients in the placebo group, and 106 and 105 patients in the two levetiracetam dosage groups, respectively.*
This appears to be a table showing percentages of patients in a study related to the medication Levetiracetam compared to a placebo group. It is unclear what the percentages represent as there are no column or row labels. The text also includes special characters such as "%" and "@", which may suggest that the original document was not properly converted to text via .*
The text "45.2%" appears to be a statistic and does not provide enough information to generate a useful description. The rest of the text refers to a study with a placebo group and a group taking levetiracetam, a medication commonly used to treat seizures. However, without more context or information about the study, a description cannot be provided.*
* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.